Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ContraFect Corp
CFRXQ
Healthcare
Biotechnology
ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its lead DLA product candidate, exebacase, is used for the treatment of methicillin-resistant S. aureus...
(MRSA) bloodstream infections (bacteremia), including right-sided endocarditis, when used in addition to standard-of-care (SOC) anti-staphylococcal antibiotics in adult patients. Its exebacase is being studied in an ongoing Phase Ib/II study in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci. Its other product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumanni, and has demonstrated potent in vivo activity against these pathogens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:CFRXQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 15, 2023 8:00am
New Press Release - ContraFect Reports First Quarter 2023 Financial Results and Provides Business Update
YONKERS, N.Y., May 15, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation(Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 28, 2023 8:55am
CFRX..... You've all been had
Again Happy Fryday !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 3:47pm
CFRX....stopped out
Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 3:41pm
CFRX....expect the unexpected
This could pop..... $2.50 target My 1st entry here at $1.93 Fingers crossed....tight stop ; )
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 3:23pm
CFRX..... N.L.O.D $2.03
What can I say ? I won't say it ; )
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 1:18pm
CFRX.... Just when u think it's a sideways action
It breaks support and goes lower Leopards don't change spots Neither do Maggots
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 12:56pm
CFRX.... N.L.O.D $2.12
Playin possum Mr. M????
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 12:27pm
CFRX....last support now.... $2.14
Has to hold or the next support is $1.95 down to $1.88
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 12:04pm
CFRX.... Now in "sideways action"...call it range bound
Support at $2.14......resistance $2.37 Trade accordingly
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 11:48am
CFRX..... further erosion after the futile attempt
to get back to $2.50 A break of $2.13 is .... "done for the day" and will end up Red
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 11:02am
CFRX.... thru DTL....just barely
If ....big if.....This gets thru $2.50 with a big volume increase.....it might get my attention....other than that....watch out for continued errosion of the shar price JMHO
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 10:43am
CFRX...go ahead...try and pick the intra-day bottom
You will get fried
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 10:41am
CFRX...... No News means.....
All the a.m Chasers get burnt As usual
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 10:28am
CFRX..... CRash to N.L.O.D
What a game
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 27, 2023 10:25am
CFRX.... Vol increase and sh price action
Thru res at $2.50 Needs way more volume on the 5 min chart
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.